GOVERNMENT
Stanford SKOLAR Announces Bio & Chem Terrorism Database Available
PALO ALTO, CA -- Stanford SKOLAR MD, an online medical knowledge system and Stanford University's first Internet venture, today announced a new database immediately available for physicians and consumers on biological and chemical terrorism. Existing Stanford SKOLAR MD subscribers can access the Biological and Chemical Terrorism Database in the News and Commentary section of SKOLAR.
Non-subscribers can visit the SKOLAR Web site at www.skolar.com and register for a free 10-day trial, which will provide them also with access to the Database. After non-subscribers register, please visit the News and Commentary section to reach the Database.
"In light of recent events and growing world-wide concern over bio-terrorism, healthcare professionals, as well as consumers, have expressed an immediate need for a trusted source of information about anthrax and other biological threats," said former Speaker Newt Gingrich, CEO of the Gingrich Group and member of the Defense Policy Board. "SKOLAR's Biological and Chemical Terrorism Database provides concise fact sheets pertaining to biological and chemical terrorism."
SKOLAR's new Biological and Chemical Terrorism Database provides up to date information collected and reviewed by a committee of Stanford University Medical School physicians and was compiled from several sources including the CDC, New York City Department of Health and the Johns Hopkins University Center for Civilian Biodefense Studies.
SKOLAR, Inc. is Stanford University's first branded Internet spin-off. Its flagship product, Stanford SKOLAR MD, delivers integrated searches across multiple, trusted reference sources, giving physicians a rapid response and superior source of information that facilitates the decision process on individual patients at the point-of-practice.
Stanford SKOLAR MD was originally developed for staff physicians and students at Stanford Medical School and was spun off in May 2000. Stanford University retains a majority stake in SKOLAR, and panels of experts drawn from the Stanford School of Medicine help to oversee content.
Stanford SKOLAR MD enables physicians to earn American Medical Association Physician Recognition Award (AMA PRA) Category 1 CME credits by answering questions that arise in the course of practice.